Total Funding
29
67
Total FundingSeed raised
Growth Score
-2 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
69583
Elgia Therapeutics is a biopharmaceutical company.
- Michael Karin: Founder
- Alan Saltiel: Co-founder and CEO
About the Company
Elgia Therapeutics is a biotechnology company that specializes in novel approaches for the treatment of chronic inflammatory and fibrotic diseases. It specializes in the fields of healthcare, therapeutics, pharmaceutical, and medicine. It is creating innovative medicines for debilitating chronic diseases. It has discovered how metabolic stress
drives inflammation and fibrosis and has identified untapped protein targets for small molecule drug discovery.
Women Founded
